Stay updated on SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page is updated to revision v3.0.2 (replacing v3.0.1); the 'Back to Top' element has been removed as a minor UI change.
    Difference
    0.1%
    Check dated 2025-09-13T17:40:15.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-06T15:21:55.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, as well as resources related to head and neck squamous cell carcinoma and various medical procedures. Notably, the version has been updated from v2.16.12 to v3.0.0.
    Difference
    3%
    Check dated 2025-08-30T12:01:20.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:43:33.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-08T23:56:11.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and the previous service alert regarding planned maintenance has been removed.
    Difference
    0.8%
    Check dated 2025-08-01T19:32:07.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in Head and Neck Carcinoma Clinical Trial page.